Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar V Parikh

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
BMC Psychiatry|May 10, 2023
Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemicIlya Demchenko, Vanessa K Tassone, Sarah Dunnett, et al.
Bipolar Disorders|March 26, 2013
Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelinesAyal Schaffer, Sagar V Parikh, Sidney H Kennedy, et al.
The Journal of ECT|June 25, 2025
Evolution of Electroconvulsive Therapy Practice During the COVID-19 Pandemic: A Systematic ReviewJosh Martin, Argyrios Perivolaris, Nadeen M Tantash, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Psychological Medicine|August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 reportMehri Sajjadian, Rudolf Uher, Keith Ho, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 10, 2020
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Journal of Psychiatric Research|January 25, 2019
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
BMC Medical Genetics|January 7, 2014
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1Wei Xu, Sarah Cohen-Woods, Qian Chen, et al.
Bipolar Disorders|May 8, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, et al.
Journal of Psychiatric Research|May 19, 2019
Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapiesJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
BMC Psychiatry|May 10, 2023
Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemicIlya Demchenko, Vanessa K Tassone, Sarah Dunnett, et al.
Bipolar Disorders|March 26, 2013
Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelinesAyal Schaffer, Sagar V Parikh, Sidney H Kennedy, et al.
The Journal of ECT|June 25, 2025
Evolution of Electroconvulsive Therapy Practice During the COVID-19 Pandemic: A Systematic ReviewJosh Martin, Argyrios Perivolaris, Nadeen M Tantash, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Psychological Medicine|August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 reportMehri Sajjadian, Rudolf Uher, Keith Ho, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 10, 2020
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Journal of Psychiatric Research|January 25, 2019
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
BMC Medical Genetics|January 7, 2014
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1Wei Xu, Sarah Cohen-Woods, Qian Chen, et al.
Bipolar Disorders|May 8, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, et al.
Journal of Psychiatric Research|May 19, 2019
Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapiesJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
Pageof 19